TScan Therapeutics, Inc.
TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic m…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
TScan Therapeutics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
TScan Therapeutics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of TScan Therapeutics, Inc..